we are only focusing on XPD here, not all chinese stocks. Not al stocks are alike sure XPD does have it problems. But the current price is also very attractive, and factors those risks in already.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game